Collectively, we demonstrate that the Fyn-PKCδ signaling axis plays a major pathological role in mediating nigral dopaminergic neurodegeneration and that the upstream regulator Fyn could serve as a potential therapeutic target for the development of disease-modifying therapies for the treatment of PD and other related neurodegenerative disorders. Here, FYN is linked to Parkinson disease.